NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.00K | 79.00K | 34.00K | 26.00K | 8.79M |
| Total Receivables | 24.00K | 23.00K | 26.00K | 26.00K | 41.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 650.00K | 873.00K | 1.25M | 1.57M | 1.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 229.00K | 274.00K | 297.00K | 313.00K | 322.00K |
| Total Current Assets | 911.00K | 1.25M | 1.61M | 1.93M | 10.35M |
|
|
|||||
| Total Current Assets | 911.00K | 1.25M | 1.61M | 1.93M | 10.35M |
| Net Property, Plant & Equipment | 13.99M | 14.31M | 14.62M | 14.46M | 14.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 93.00K | 93.00K | 91.00K | 92.00K | 90.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.00M | 15.65M | 16.32M | 16.48M | 25.20M |
|
|
|||||
| Total Accounts Payable | 13.45M | 12.69M | 12.84M | 11.04M | 7.94M |
| Total Accrued Expenses | 2.32M | 2.30M | 2.36M | 2.27M | 4.97M |
| Short-term Debt | 19.70M | 17.25M | 11.57M | 9.99M | 5.23M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 154.00K | 154.00K | 154.00K | -- | 96.00K |
| Total Finance Division Other Current Liabilities | 1.49M | 19.01M | 10.57M | 16.15M | 20.61M |
| Total Other Current Liabilities | 1.49M | 19.01M | 10.57M | 16.15M | 20.61M |
| Total Current Liabilities | 37.12M | 51.41M | 37.48M | 39.45M | 38.85M |
|
|
|||||
| Total Current Liabilities | 37.12M | 51.41M | 37.48M | 39.45M | 38.85M |
| Long-Term Debt | 10.60M | 10.37M | 10.15M | 9.93M | 14.71M |
| Short-term Debt | 19.70M | 17.25M | 11.57M | 9.99M | 5.23M |
| Capital Leases | 282.00K | 316.00K | 348.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.04M | 23.27M | 23.39M | 25.79M | 12.28M |
| Total Liabilities | 62.05M | 85.37M | 71.37M | 75.17M | 65.84M |
|
|
|||||
| Common Stock & APIC | 130.20M | 124.59M | 122.85M | 121.73M | 120.80M |
| Retained Earnings | -177.00M | -183.60M | -167.51M | -162.13M | -161.44M |
| Treasury Stock & Other | -251.00K | -10.71M | -10.39M | -18.29M | -- |
| Total Common Equity | -47.05M | -69.72M | -55.06M | -58.69M | -40.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.05M | -69.72M | -55.06M | -58.69M | -40.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -47.05M | -69.72M | -55.06M | -58.69M | -40.64M |
|
|
|||||